1. AB0185 Endothelin-1 stimulates the profibrotic alternative activated phenotype in cultured human macrophages isolated from systemic sclerosis patients. (15th June 2017) Authors: Soldano, S; Montagna, P; Brizzolara, R; Trombetta, AC; Corallo, C; Pizzorni, C; Paolino, S; Sulli, A; Ghio, M; Smith, V; Giordano, N; Cutolo, M Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. From microvasculature to fibroblasts: Contribution of anti-endothelial cell antibodies in systemic sclerosis. (March 2015) Authors: Corallo, C; Franci, B; Lucani, B; Montella, A; Chirico, C; Gonnelli, S; Nuti, R; Giordano, N Journal: International journal of immunopathology and pharmacology Issue: Volume 28:Number 1(2015) Page Start: 93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP0082 Fibrosis and microangiopathy are the main histopathological hallmarks of scleroderma-related myopathy. (15th June 2017) Authors: Corallo, C; Cutolo, M; Soldano, S; Volpi, N; Franci, D; Montella, A; Chirico, C; Nuti, R; Giordano, N Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SAT0323 The endothelial-to-mesenchymal transition (ENDOMT) in scleroderma can be prevented by the use of dual endothelin receptor antagonists bosentan and macitentan. (15th June 2017) Authors: Corallo, C; Cutolo, M; Soldano, S; Montella, A; Chirico, C; Nuti, R; Giordano, N Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 894 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗